Tiziana Life Sciences CEO Increases Stake With Share Purchase

MT Newswires Live12-16

Tiziana Life Sciences (TLSA) said Monday its CEO, Ivor Elrifi, purchased 163,400 shares of common stock, bringing his total stake to 357,848 shares.

Shares of the company were down over 17% in recent trading.

Price: 1.47, Change: -0.31, Percent Change: -17.19

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment